Physician profile
Alpha MD Anders
NPI 1508493230
$1,311.40
in general payments reported to CMS, 2019-2025
11 companies · $144 in 2025
The $144 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.10 · 2022: $296 · 2023: $421 · 2024: $436 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,002.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,001.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $443.35 | 2023-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Synchromedii |
| Merz Pharmaceuticals, LLC | $388.85 | 2022-2024 | Xeomin |
| Avanos Medical | $157.89 | 2023 | Generator |
| Nevro Corp. | $123.97 | 2024 | Senza |
| Abbvie INC. | $49.71 | 2022-2023 | Botox |
| Spr Therapeutics, INC | $43.80 | 2025 | Sprint Pns System |
| Pfizer INC. | $31.11 | 2023 | |
| Saluda Medical Americas, INC. | $26.09 | 2025 | Evoke |
| Averitas Pharma INC. | $17.83 | 2024 | Qutenza |
| Azurity Pharmaceuticals, INC. | $15.70 | 2024 | Horizant |
| Stryker Corporation | $13.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alpha Anders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.